Profiling breast cancer by array CGH

Breast Cancer Research and Treatment

Volumn 78, Issue 3, 2003, Pages 289-298

  Albertson, Donna G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Array CGH; Copy number aberration; Genome instability

Indexed keywords

ANALYTIC METHOD; BREAST CANCER; CANCER GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE MAPPING; GENE NUMBER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC STABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; NUCLEIC ACID HYBRIDIZATION;

EID: 0037738895     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023025506386     Document Type: Review

References (40)

1. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001
2. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992
3. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407, 1997
4. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW, Albertson DG: Quantitative high resolution analysis of DNA copy number variation in breast cancer using comparative genomic hybridization to DNA microarrays. Nat Genet 20: 207-211, 1998
5. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46, 1999
6. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG: Assembly of microarrays for genome-wide measurement of DNA copy number by CGH. Nat Genet 29: 263-264, 2001
7. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G: Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. USA 96: 4494-4499, 1999
8. Snijders AM, Segraves R, Blackwood S, Pinkel D, Albertson DG: BAC microarray-based comparative genomic hybridization. In: Zhao S, Stodolsky M (eds), Bacterial Artificial Chromosomes: Methods and Protocols, Methods in Molecular Biology, Humana Press, 2002 (in press)
9. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW, Pinkel D: Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146, 2000
10. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar A: Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58: 3237-3242, 1998
11. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996
12. Hosokawa Y, Arnold A: Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22: 66-71, 1998
13. Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Ljung BM: Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92: 313-320, 2000
14. Muleris M, Dutrillaux AM, Olschwang S, Salmon RS, Dutrillaux B: Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 14: 223-226, 1995
15. Kuo MT, Vyas RC, Jiang L-X, Hittelman WN: Chromosomal breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 14: 5202-5211, 1994
16. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M: Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225, 1997
17. Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR: MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol 18: 536-545, 1998
18. Paulson TG, Almasan A, Brody LL, Wahl GM: Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 18: 3089-3100, 1998
19. Pipiras E, Coquelle A, Bieth A, Debatisse M: Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 17: 325-333, 1998
20. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B: A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1: 89-97, 2002
21. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M: Double-strand breaks and tumorigenesis. Trends Cell Biol 11: S52-S59, 2001
22. Forsyth NR, Wright WE, Shay JW: Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69: 188-197, 2002
23. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97: 503-514, 1999
24. Riboni R, Casati A, Nardo T, Zaccaro E, Ferretti L, Nuzzo F, Mondello C: Telomeric fusions in cultured human fibroblasts as a source of genomic instability. Cancer Genet Cytogenet 95: 130-136, 1997
25. McClintock B: Spontaneous alterations in chromosome size and form in Zea mays. Cold Spring Harb Symp Quant Biol 9: 72-81, 1941
26. Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung B-M, Waldman FM: Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32: 292-296, 2001
27. Tsarouha H, Pandis N, Bardi G, Teixeira MR, Andersen JA, Heim S: 1999. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet Cytogenet 113: 156-161, 1998
28. Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, Thor A: Genomic alterations in tubular breast carcinomas. Hum Patrol 32: 222-226, 2001
29. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F: Whole-arm t(1;16) and I(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235-238, 1992
30. Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M: DNA hypomethylation and unusual chromosome instability in ceil lines from ICF syndrome patients. Cytogenet Cell Genet 89: 121-128, 2000
31. Narayan A, Ji W, Zhang XY, Marrogi A, Graft JR, Baylin SB, Ehrlich M: Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 77: 833-838, 1998
32. Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21, 2001
33. Lingle WL, Barret SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99: 1978-1983, 2002
34. Oki E, Oda S, Maehara Y, Sugimachi K: Mutated genespecific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repain Oncogene 18: 2143-2147, 1999
35. Tlsty TD: Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci USA 87: 3132-3136
36. Rizki A, Lundblad V: Defects in mismatch repair promote telomerase-independent proliferation. Nature 411: 713-716, 2001
37. Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610, 2002
38. Baselga J: Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Oncology 61 Suppl 2: 14-21, 2001
39. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W: The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2: 116-123, 2000
40. Bastian BC, Wesselmann U, Pinkel D, Leboit PE: Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113: 1065-1069, 1999